CN100387574C - 丙磺舒钠、丙磺舒钾的制备工艺 - Google Patents
丙磺舒钠、丙磺舒钾的制备工艺 Download PDFInfo
- Publication number
- CN100387574C CN100387574C CNB2004100112874A CN200410011287A CN100387574C CN 100387574 C CN100387574 C CN 100387574C CN B2004100112874 A CNB2004100112874 A CN B2004100112874A CN 200410011287 A CN200410011287 A CN 200410011287A CN 100387574 C CN100387574 C CN 100387574C
- Authority
- CN
- China
- Prior art keywords
- probenecid
- potassium
- sodium
- beta
- white
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 title claims abstract description 71
- 229960003081 probenecid Drugs 0.000 title claims abstract description 35
- 238000002347 injection Methods 0.000 title claims abstract description 29
- 239000007924 injection Substances 0.000 title claims abstract description 29
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 229910052700 potassium Inorganic materials 0.000 title claims abstract description 25
- 239000011591 potassium Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 150000001875 compounds Chemical class 0.000 title abstract description 11
- 239000003782 beta lactam antibiotic agent Substances 0.000 title abstract 6
- 239000002132 β-lactam antibiotic Substances 0.000 title abstract 6
- 229940124586 β-lactam antibiotics Drugs 0.000 title abstract 6
- QCCCFHDTBTUDEA-UHFFFAOYSA-M sodium;4-(dipropylsulfamoyl)benzoate Chemical compound [Na+].CCCN(CCC)S(=O)(=O)C1=CC=C(C([O-])=O)C=C1 QCCCFHDTBTUDEA-UHFFFAOYSA-M 0.000 title abstract 3
- 239000000843 powder Substances 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 21
- 229910052708 sodium Inorganic materials 0.000 claims description 21
- 239000011734 sodium Substances 0.000 claims description 21
- 239000002994 raw material Substances 0.000 claims description 17
- 238000011082 depyrogenation Methods 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 16
- 239000012528 membrane Substances 0.000 claims description 16
- 238000005374 membrane filtration Methods 0.000 claims description 16
- 239000008213 purified water Substances 0.000 claims description 16
- 238000012546 transfer Methods 0.000 claims description 16
- 239000008215 water for injection Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 229940088710 antibiotic agent Drugs 0.000 abstract description 2
- 159000000001 potassium salts Chemical class 0.000 abstract 2
- 230000002035 prolonged effect Effects 0.000 abstract 2
- 159000000000 sodium salts Chemical class 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960003311 ampicillin trihydrate Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 125000004914 dipropylamino group Chemical group C(CC)N(CCC)* 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229960002727 cefotaxime sodium Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100112874A CN100387574C (zh) | 2004-12-01 | 2004-12-01 | 丙磺舒钠、丙磺舒钾的制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100112874A CN100387574C (zh) | 2004-12-01 | 2004-12-01 | 丙磺舒钠、丙磺舒钾的制备工艺 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006100590184A Division CN1853724A (zh) | 2004-12-01 | 2004-12-01 | 丙磺舒钠、钾与β-内酰胺类抗生素组成复方针剂及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1631876A CN1631876A (zh) | 2005-06-29 |
CN100387574C true CN100387574C (zh) | 2008-05-14 |
Family
ID=34845614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100112874A Active CN100387574C (zh) | 2004-12-01 | 2004-12-01 | 丙磺舒钠、丙磺舒钾的制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100387574C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102924344A (zh) * | 2012-10-10 | 2013-02-13 | 北京康正康仁生物科技有限公司 | 丙磺舒钠、丙磺舒钾的合成制备方法 |
CN102976980B (zh) * | 2012-12-07 | 2014-06-25 | 山东省化工研究院 | 丙磺舒纯化方法 |
CN102976979B (zh) * | 2012-12-07 | 2014-08-20 | 山东省化工研究院 | 一种水溶性丙磺舒盐的制备方法 |
CN112076161B (zh) * | 2020-08-07 | 2022-10-18 | 安徽康正康仁药业有限公司 | 一种头孢菌素类钠盐与丙磺舒钠组成的复方冻干制剂 |
CN111704562A (zh) * | 2020-08-07 | 2020-09-25 | 安徽康正康仁药业有限公司 | 一种盘装丙磺舒钠无菌原料药冻干工艺 |
CN111840236B (zh) * | 2020-08-07 | 2022-09-02 | 安徽康正康仁药业有限公司 | 一种注射用美罗培南丙磺舒钠复方冻干制剂 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1223097A (en) * | 1968-04-17 | 1971-02-24 | Merck M Co Inc | Sulphonamide salt |
JPS52105220A (en) * | 1976-02-28 | 1977-09-03 | Toyama Chem Co Ltd | Composition for rectal administration comprising beta-lactam ring containing substance and method of making same |
-
2004
- 2004-12-01 CN CNB2004100112874A patent/CN100387574C/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1223097A (en) * | 1968-04-17 | 1971-02-24 | Merck M Co Inc | Sulphonamide salt |
JPS52105220A (en) * | 1976-02-28 | 1977-09-03 | Toyama Chem Co Ltd | Composition for rectal administration comprising beta-lactam ring containing substance and method of making same |
Also Published As
Publication number | Publication date |
---|---|
CN1631876A (zh) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2547348B1 (en) | Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions | |
CN102871996A (zh) | 一种抗菌药物组合物及其应用 | |
CN100387574C (zh) | 丙磺舒钠、丙磺舒钾的制备工艺 | |
SU1071226A3 (ru) | Способ получени антибиотической смеси | |
CN102008445A (zh) | 阿莫西林可溶性粉及其制备方法和应用 | |
CN101297809B (zh) | 头孢哌酮钠与舒巴坦钠混粉的制备方法 | |
CN105418641B (zh) | 一种原研制品质头孢曲松钠及其药物制剂 | |
CN103920137B (zh) | 一种具有抗耐药性革兰阳性细菌作用的药物组合物 | |
CN1259041C (zh) | 注射用盐酸溴己新无菌冻干制剂及其制备方法 | |
CN101249092A (zh) | 一种抗感染的含有最佳配比的头孢哌酮钠和舒巴坦钠的药物组合物及其制备方法 | |
CN104027369A (zh) | 一种含有白花丹和诺氟沙星的畜禽用复方组合物 | |
CN104958778A (zh) | 一种口腔抑菌促愈合材料及其应用 | |
CN101548979A (zh) | 一种治疗肠炎、菌痢的药物新组合 | |
CN101648001A (zh) | 兽用复方硫酸安普霉素可溶性粉及其应用 | |
CN103059045B (zh) | 一种阿莫西林钠克拉维酸钾化合物及其药物组合物 | |
CN101474176B (zh) | 一种氟氯西林钠阿莫西林钠药物组合物及其制法 | |
CN102786536A (zh) | 治疗猪急性细菌性感染的舒巴坦阿莫西林酰胺复合物及合成方法 | |
CN103908670A (zh) | 一种治疗畜禽大肠杆菌感染疾病的复方组合物 | |
CN113337275A (zh) | 一种抗菌aie材料及其制备方法 | |
CN108840940B (zh) | 一种嵌合肽a6及其应用 | |
CN102370656A (zh) | 克拉霉素药物组合物及其制备方法 | |
CN1817868A (zh) | 一组抗厌氧菌感染的奥硝唑类衍生物及其制备方法 | |
CN1203862C (zh) | 复方克林霉素甲硝唑葡萄糖注射液 | |
CN102580093A (zh) | 预防仔猪疾病的注射液及其制备方法 | |
CN101991591A (zh) | 复方硫酸安普霉素注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING KANGZHENG KANGREN BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WU XIAOHUI Effective date: 20120515 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 130021 CHANGCHUN, JILIN PROVINCE TO: 102200 CHANGPING, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120515 Address after: 102200, B272, room 1, 29 life road, Changping District science and Technology Park, Beijing, China Patentee after: Beijing Kangzheng Kangren Biotechnology Co., Ltd. Address before: Chaoyang District City, Guilin Road province Jilin 130021 Changchun No. 56 (Medical University dormitory No. 151 6-2) Patentee before: Wu Xiaohui |